EP3634581
Samsetningar til notkunar við meðferð á meðfæddri niðurgangsröskun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.5.2018EP published:
31.7.2024EP application number:
18810153.9
EP translation filed:
15.8.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
30.5.2038Expiry date:
30.5.2026Next due date:
31.5.2026
Title in English:
COMPOSITIONS FOR USE IN TREATING CONGENITAL DIARRHEA DISORDERLanguage of the patent:
English
Timeline
Today
31.5.2018EP application
31.7.2024EP Publication
15.8.2024Translation submitted
15.9.2024Registration published
30.5.2026Expires
Owner
Name:
Napo Pharmaceuticals, Inc.Address:
200 Pine Street, Suite 400, San Francisco, CA 94104, US
Inventor
Name:
CONTE, Lisa, A.Address:
San Francisco CA 94105, US
Name:
CHATURVEDI, Pravin, R.Address:
Andover MA 01810, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762513251 PDate:
31.5.2017Country:
US
Classification
Categories:
A61K 36/47, A61K 31/535, A61K 9/00, A61K 9/20, A61K 9/48, A61P 1/00, A61P 1/04, A61P 1/12, A61K 9/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 27.5.2025
Expires: 30.5.2026
Payer: Árnason Faktor ehf.